500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA
Market cap: $6.2B (2/08/2026)
Price: $79.02
Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
Announces Pricing of Upsized $602 Million Public Offering
Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis
Announces Third Quarter 2025 Financial Results and Provides a Business Update
Appoints Brian Adams as Chief Legal Officer and Corporate Secretary
Announces Second Quarter 2025 Financial Results and Provides a Business Update
Announces Pricing of $250 Million Public Offering
Shareholder votes
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence